Does RANOLAZINE Cause Toe amputation? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Toe amputation have been filed in association with RANOLAZINE (Ranolazine). This represents 0.1% of all adverse event reports for RANOLAZINE.
7
Reports of Toe amputation with RANOLAZINE
0.1%
of all RANOLAZINE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Toe amputation From RANOLAZINE?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Toe amputation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Toe amputation?
CANAGLIFLOZIN (2,193)
CANAGLIFLOZIN\METFORMIN (196)
EMPAGLIFLOZIN (149)
INSULIN GLARGINE (133)
ADALIMUMAB (124)
METFORMIN (103)
BECAPLERMIN (102)
ETANERCEPT (100)
METHOTREXATE (84)
TOCILIZUMAB (66)
Which RANOLAZINE Alternatives Have Lower Toe amputation Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ